Aeromonas vernix outer membrane porin with broad-spectrum immune protection and application thereof
By screening and expressing the outer membrane porin Porin OmpA of AVA and combining it with oil adjuvant, the problem of insufficient resistance of freshwater fish to AVA and AVA hydrophilus is solved, and the problem of freshwater fish is achieved. It has broad-spectrum immune protection and has important vaccine development potential.
Patent Information
- Application Number
- CN202410354739.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-03-27
- Publication Date
- 2024-11-29
- Estimated Expiration
- 2044-03-27
AI Technical Summary
The prior art is difficult to effectively prevent bacterial sepsis in freshwater fish, especially diseases caused by Aeromonas Vickers and Aeromonas hydrophila, and the widespread use of antibiotics leads to bacterial resistance and ecological and environmental hazards.
The outer membrane porin OmpA of Aeromonas Vickers with broad-spectrum immune protection was screened, and the recombinant protein was obtained through E. coli expression, and emulsified with oil adjuvant in an appropriate proportion. It was used to immunize freshwater fish to improve its response to both resistance to a pathogen.
This method significantly improves the resistance of freshwater fish to Aeromonas Vickers and Aeromonas hydrophila, provides broad-spectrum immune protection, and has potential genetically engineered subunit vaccine and nucleic acid vaccine development value.
Smart Images

Figure CN118255850B_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of biomedicine, and in particular to an Aeromonas veronii outer membrane porin with broad-spectrum immune protection and an application thereof. Background Art
[0002] Freshwater fish bacterial septicemia is an acute infectious disease that has harmed the most species of freshwater fish in the history of fish farming in my country, with the widest epidemic area, the longest epidemic season, and the greatest losses. It is a Class II animal epidemic disease announced by the Ministry of Agriculture and Rural Affairs. It mainly harms freshwater farmed animals such as grass carp, silver carp, bighead carp, carp, crucian carp, bream, mandarin fish, sea bass, tilapia, channel catfish, turtle and frog. The peak period of the disease is usually from June to September each year, and acute outbreaks often occur with a high mortality rate. Most sick fish have symptoms of hemorrhagic septicemia, such as bleeding at the base of fin rays, red and swollen anus, bleeding spots on the body surface, and swollen abdomen. Some sick fish have bloody ascites in the abdominal cavity.
[0003] Aeromonas spp. is the main pathogen of bacterial septicemia in freshwater fish. It is a type of Gram-negative conditional pathogen that is widely present in aquatic environments such as freshwater, seawater, sewage, and drinking water. It can cause human traumatic infection and food poisoning. In recent years, studies have shown that Aeromonas spp. accounts for the highest proportion of pathogens of bacterial septicemia in freshwater fish, followed by Aeromonas hydrophila, and mixed infections are common. At present, bacterial diseases are mainly controlled by antibiotics. However, the widespread use of antibiotics not only makes some bacteria resistant, but also endangers the ecological environment and human health. The use of vaccines to prevent bacterial diseases has gradually received attention, but whole-bacterial vaccines are limited by serotypes. Therefore, broad-spectrum protective antigens are a key direction in the development of bacterial disease vaccines.
[0004] Outer membrane proteins (Omps) are the main structures in the outer membrane of Gram-negative bacteria. Various proteins embedded in the outer membrane layer are potential candidate antigens. Outer membrane proteins play an important role in infecting hosts, transporting substances, maintaining outer membrane structure, synthesizing related substances, and drug resistance. Studies have shown that bacterial outer membrane proteins have good antigenicity and can stimulate the body's humoral and cellular immunity. Bacterial outer membrane proteins have a certain immune cross-protection between different serotypes of bacteria and are potential broad-spectrum immune protective antigens.
[0005] Chinese patent application document CN104961811A provides a prokaryotic expression protein ompA of the outer membrane protein gene of Aeromonas hydrophila, which can be used as a vaccine with a protective effect on fish. The immune effect of the prokaryotic expression protein pompA of the outer membrane protein gene of Aeromonas hydrophila on channel catfish under the action of different FIAs was compared. Chinese patent application document CN115715800 A discloses a subunit nanovaccine of Aeromonas hydrophila, comprising OMP P5 protein, immune adjuvant, cationic lipid, surfactant and hydrophobic stabilizer. The above-constructed recombinant protein vaccines are all directed against a single pathogen-Aeromonas hydrophila, and have an immune protection effect on the test fish. Summary of the invention
[0006] In view of the above problems, the present invention screened out an outer membrane porin PorinOmpA with broad-spectrum immune protection, and obtained a recombinant outer membrane porin by expression in Escherichia coli. It has good antigenicity, and after being emulsified with an oil adjuvant in an appropriate proportion, it can be used to immunize freshwater fish, and can improve the ability of freshwater fish to resist two pathogens, Aeromonas veronii and Aeromonas hydrophila, and has a broad-spectrum immune protection.
[0007] The technical solution of the present invention includes:
[0008] In a first aspect, the present invention provides an Aeromonas veronii outer membrane porin having a broad-spectrum immune protection effect, wherein the outer membrane porin is Porin OmpA, and its amino acid sequence is SEQ ID NO.2.
[0009] Preferably, the nucleotide sequence of the gene encoding the outer membrane porin is SEQ ID NO.1.
[0010] In a second aspect, the present invention also provides the use of the above-mentioned Aeromonas veronii outer membrane porin with broad-spectrum immune protection in the preparation of a vaccine preparation for preventing Aeromonas veronii and Aeromonas hydrophila in freshwater fish.
[0011] In the above technical solution, the freshwater fish can be freshwater fish such as grass carp, silver carp, bighead carp, carp, crucian carp, bream, bream, mandarin fish and perch.
[0012] In a third aspect, the present invention also provides a vaccine preparation for preventing infection by Aeromonas veronii and Aeromonas hydrophila, the vaccine preparation comprising rPorin OmpA protein, and the rPorin OmpA protein is the recombinant outer membrane porin Porin OmpA of the above-mentioned Aeromonas veronii with broad-spectrum immune protection.
[0013] Preferably, the rPorin OmpA protein is obtained by recombinant expression in Escherichia coli.
[0014] Preferably, an oily adjuvant is also included.
[0015] Further preferably, the oily adjuvant is any one of ISA 763A and white oil.
[0016] Further preferably, the volume ratio of the oily adjuvant to the rPorin OmpA protein is 1:1 to 2:1.
[0017] Further preferably, the final concentration of the rPorin OmpA protein in the vaccine preparation is 0.1-1.0 mg / mL, such as 0.1 mg / mL, 0.2 mg / mL, 0.4 mg / mL, 0.8 mg / mL, 1.0 mg / mL, etc.
[0018] Compared with the prior art, the present invention has the following beneficial effects:
[0019] The outer membrane porin Porin OmpA of Aeromonas veronii screened out by the present invention with broad-spectrum immune protection is expressed in Escherichia coli to obtain a recombinant protein rPorin OmpA. The recombinant protein has good antigenicity, and after being emulsified with an oil adjuvant in an appropriate proportion, it is used to immunize freshwater fish such as grass carp, and can improve the ability of grass carp and freshwater fish to resist two pathogens, Aeromonas veronii and Aeromonas hydrophila, and has a broad-spectrum immune protection. The outer membrane porin protein and its gene sequence can be further studied and developed as a genetic engineering subunit vaccine and a nucleic acid vaccine for freshwater fish bacterial sepsis. BRIEF DESCRIPTION OF THE DRAWINGS
[0020] Figure 1 (A) SDS-PAGE and (B) Western-blot patterns of total outer membrane proteins Omps of Aeromonas hydrophila and Aeromonas veronii (M: Marker; 1: A. veronii AVCA07; 2: A. veronii YC170511; 3: A. veronii XZ190501; 4: A. veronii FS12001; 5: A. veronii Hm0910; 6: A. veronii Ci0914; 7: A. hydrophila Hn099; 8: A. hydrophila NJ-35; 9: A. hydrophila J-1);
[0021] Figure 2 The complete gene sequence of porin ompA of Aeromonas vermifuge AVCA07;
[0022] Figure 3 The amino acid sequence of Porin OmpA of Aeromonas veronii AVCA07;
[0023] Figure 4Construction and identification of pET32a-porin recombinant expression vector;
[0024] Figure 5 (A) SDS-PAGE and (B) Western-blot of recombinant outer membrane protein rPorin;
[0025] Figure 6 Serum antibody titer;
[0026] Figure 7 Cumulative mortality graph of the immunized group and the control group (challenged with Aeromonas victoriae AVCA07);
[0027] Figure 8 Cumulative mortality chart of the immunized group and the control group (challenged with Aeromonas hydrophila Hn099). DETAILED DESCRIPTION
[0028] For ease of understanding of the present invention, the embodiments of the present invention will be described in detail below in conjunction with examples, but those skilled in the art will appreciate that the following examples are only used to illustrate the present invention and should not be considered to limit the scope of the present invention. If specific conditions are not specified in the examples, they are carried out according to normal conditions or conditions recommended by the manufacturer. If the manufacturer is not specified for the reagents or instruments used, they are all conventional products that can be obtained commercially.
[0029] Example 1 Extraction and antigenicity analysis of total outer membrane proteins of Aeromonas vernix and Aeromonas hydrophila
[0030] The total outer membrane protein Omps of Aeromonas vernix and Aeromonas hydrophila strains was prepared by the Sarkosyl method. Each strain was cultured overnight on a shaking table and centrifuged to obtain the bacterial cells; resuspended in 20ml Tris-HCL and ultrasonically disrupted; centrifuged to obtain the supernatant; the supernatant was centrifuged at high speed to obtain the precipitate; the precipitate was resuspended in 0.5% sodium lauroyl sarcosinate (SLS) and incubated at 4°C overnight; centrifuged for 30 minutes to remove SLS, and Omps was resuspended in 1.5ml ddH2O for SDS-PAGE and Western-blot analysis. In Western-blot, Aeromonas vernix AVCA07 Omps rabbit antiserum (1:500) was used as the first antibody, and HRP-labeled goat anti-rabbit IgG monoclonal antibody (1:2000) was used as the second antibody.
[0031] SDS-PAGE results are as follows Figure 1 The results showed that the total outer membrane protein Omps of 6 Aeromonas verumii and 3 Aeromonas hydrophila strains were diverse, with molecular weights mainly distributed in the range of 20-50 kDa ( Figure 1A). Western-blot results showed that the rabbit antiserum against the total outer membrane protein Omps of Aeromonas AVCA07 could specifically recognize the outer membrane protein of this strain and other strains, which is about 37 kDa Omps ( Figure 1 B). It can be seen that Omps with a molecular weight of about 37 kDa contains a broad spectrum of outer membrane protein antigens of Aeromonas veronii and Aeromonas hydrophila.
[0032] Example 2 Analysis of target protein by liquid chromatography tandem mass spectrometry (LC-MS / MS)
[0033] Take the Omps of Aeromonas victorii strain AVCA07 for SDS-PAGE and stain with Coomassie Brilliant Blue R-250. Cut off the single protein band containing broad-spectrum antigens with a molecular weight of about 37kDa on the test-stained gel, put it into an EP tube, and after proteolysis, peptide extraction and purification, it was analyzed and detected by Guangzhou Fitgene Biotechnology Co., Ltd. (Guangzhou Fitgene Biotechnology CO., LTD) using liquid chromatography tandem mass spectrometry (LC-MS / MS) (Thermo Scientific). The mass spectrometry results were compared in the Uniprot protein database, and a protein was identified as Porin OmpA, with accession number A0A433LSH8. Its protein score, protein quality, number of secondary spectra matched, number of secondary spectra with scores higher than the threshold, number of peptides matched, number of peptides with scores higher than the threshold, protein coverage, protein isoelectric point and protein abundance index are shown in Table 1.
[0034] Table 1 Analysis results of Porin OmpA protein
[0035]
[0036] Example 3 Cloning and sequence analysis of the complete gene of outer membrane protein porin ompA
[0037] Primers were designed with reference to the gene sequence of outer membrane protein Porin OmpA (sequence number A0A433LSH8), upstream primer porin-F (SEQ ID NO.3): 5 / -ATC GGATCC ATGAAAAAA TCATTGATTACCTTG-3 / (The underlined part is the BamHI restriction site), downstream primer porin-R (SEQ ID NO.4): 5 / -CTT GTCGAC TTACTCCTGTACCTCGC TGACAC-3 / (The underlined part is the SalⅠ restriction site). AVCA07 DNA was used as a template to amplify the entire gene of the outer membrane protein porin. The PCR program was: 94℃, 5min; 94℃30s, 57℃30s, 72℃45s, 30cycles; 72℃, 10min. The PCR product was connected to the pMD19T vector and transformed into DH5α. LB plates containing ampicillin were used for screening, and positive clones were selected and sent to Guangzhou Aiji Biotechnology Co., Ltd. for sequencing and sequence analysis.
[0038] The porin ompA full gene open reading frame of Aeromonas vernix AVCA07 is 1035 bp, and the full gene sequence is SEQ ID NO.1, as shown in Figure 2 It encodes 344aa, has a molecular weight of 37kDa, an isoelectric point pI of 5.09, and the first 20aa is a signal peptide. The complete amino acid sequence is SEQ ID NO.2, as shown in Figure 3 shown.
[0039] Example 4 Preparation of recombinant outer membrane protein rPorin OmpA and its reactivity
[0040] pMD19T-porin and pET32a were double-digested with BamHⅠ and SalⅠ, respectively. After the digestion products were recovered, T4 DNA ligase was used to connect them at 16℃ overnight to obtain the recombinant plasmid pET32a-porin. Specific bands of about 6000bp and 1100bp were obtained after double digestion of pET32a-porin. Sequencing results showed that the recombinant expression plasmid carrying porin was successfully constructed. Figure 4 As shown. Take 10 μl of the ligation product to transform DH5α, and use LB medium containing ampicillin to screen positive clones. The recombinant expression vector pET32a-porin was electroporated into Escherichia coli BL21 (DE3), and the recombinant BL21 was inoculated into LB medium containing ampicillin at a ratio of 1:1000 and cultured in a shaking incubator at 37°C. When the strain OD 600 When the value was 0.6-0.8, 1 mM IPTG was added to induce expression for 6 h. The recombinant protein inclusion bodies obtained from the induced recombinant BL21 were denatured, renatured and purified by nickel column. The protein concentration was determined by BCA method and stored at -20°C for future use.
[0041] The obtained bacteria (uninduced and induced recombinant BL21) and the purified recombinant protein were subjected to SDS-PAGE gel electrophoresis and Western-blot analysis. Figure 5 As shown. SDS-PAGE electrophoresis showed that the molecular weight of the recombinantly expressed fusion protein was about 55 kDa (including the molecular weight of the tag protein contained in pET32a of about 20 kDa) ( Figure 5A). In Western-blot, the total outer membrane protein Omps rabbit antiserum of Aeromonas victoria AVCA07 (1:500) was used as the first antibody, and the HRP-labeled goat anti-rabbit IgG monoclonal antibody (1:2000) was used as the second antibody. The Western-blot results showed that the Aeromonas victoria AVCA07 Omps rabbit antiserum as the first antibody could specifically recognize the recombinant protein band with a molecular weight of about 55 kDa ( Figure 5 B). It can be seen that the recombinant outer membrane protein rPorin OmpA has good reactogenicity.
[0042] Example 5 Fish immunization and antibody titer determination
[0043] Purified rPorin OmpA and ISA 763A were mixed in equal volumes and then emulsified to prepare rPorin-ISA 763A vaccine, wherein the final concentration of rPorin was 0.2 mg / mL. PBS and ISA 763A were mixed in equal volumes and then emulsified to prepare PBS-ISA 763A as an adjuvant.
[0044] The test fish were grass carp, each weighing 25-30g and 13-15cm in length. 100 test fish were injected intraperitoneally in the rPorin-ISA 763A group, with 200μl injected per fish. 100 test fish were injected intraperitoneally in the adjuvant control group and the PBS control group, respectively, with 200μl injected per fish. Blood was collected from 5 fish randomly selected from the immunized group and the control group at 7d, 14d, 21d, 28d, 42d and 56d after immunization, and serum was prepared for the determination of IgM antibody titer.
[0045] The serum antibody titer was determined by indirect ELISA method. The ELISA plate was coated with 2 μg / mL Porin. The serum to be tested was diluted 100 times and then diluted two-fold. The first antibody was mouse anti-grass carp IgM monoclonal antibody (1:1000), and the second antibody was HRP-labeled goat anti-mouse IgG monoclonal antibody (1:5000). Wash according to the conventional operation process, add color development solution and stop solution to stop, and measure OD 450nm and OD 630nm Value. Negative serum control and PBS control were also set up. The results showed that rPorin-ISA 763A can stimulate grass carp to produce humoral immune response. No antibody titer was detected in the immunization group on day 7, but the antibody titer reached 1:400 on day 14, rose to 1:6400 on day 21, 1:3200 on day 28, and 1:1600 on day 56 ( Figure 6 ).
[0046] Example 6 Fish immune protection effect test
[0047] After 28 days of immunization, the immunized group and the control group were randomly divided into two groups, each with 30 fish. The fish were challenged with Aeromonas vernix strain AVCA07 and Aeromonas hydrophila strain Hn099, respectively, and each fish was injected with 0.2 ml (containing about 6.0×10 viable bacteria, respectively). 7 CFU and 3.0×10 7 CFU). Each group was kept in an indoor glass tank at a water temperature of 29±1℃ and observed for 7 days. The number of dead fish in each group was recorded every day, and the relative protection rate of the immune group was calculated. The results showed that the mortality rate of the PBS control group, the PBS-ISA763A adjuvant control group, and the rPorin-ISA763A immune group was 20.0%, and the relative protection rate of the immune group was 80.0% ( Figure 7 , Table 2). The mortality rate of the PBS control group and the PBS-ISA763A adjuvant control group was 90.0%, 66.7%, and 10.0% in the rPorin-ISA763A immunization group, respectively. The relative protection rate of the immunization group was 88.9% ( Figure 8 , Table 2). It can be seen that intraperitoneal injection of rPorin-ISA763A to immunize grass carp can effectively resist infection with Aeromonas vernix and Aeromonas hydrophila.
[0048] Table 2 Relative protection rate of immunized groups after challenge with different strains
[0049]
[0050]
[0051] In summary, the present invention screened out an outer membrane porin Porin OmpA with a broad-spectrum immune protection effect from the total outer membrane protein Omps of Aeromonas vernix AVCA07 through SDS-PAGE, immunoblotting, liquid chromatography tandem mass spectrometry (LC-MS / MS) analysis and fish immune test, and evaluated the antigenicity of the recombinant protein and its immune effect on grass carp. The results showed that the recombinant protein had good antigenicity, and after being emulsified with an oil adjuvant in an appropriate proportion, it was used to immunize freshwater fish such as grass carp, and it could improve the ability of freshwater fish such as grass carp to resist two bacteria, Aeromonas vernix and Aeromonas hydrophila, and had a broad-spectrum immune protection effect. The outer membrane porin and its gene nucleotide sequence can be further studied and developed as a genetically engineered subunit vaccine and a nucleic acid vaccine for freshwater fish bacterial sepsis.
[0052] The technical features of the above-described embodiments may be arbitrarily combined. To make the description concise, not all possible combinations of the technical features in the above-described embodiments are described. However, as long as there is no contradiction in the combination of these technical features, they should be considered to be within the scope of this specification.
[0053] The above-mentioned embodiments only express several implementation methods of the present invention, and the descriptions thereof are relatively specific and detailed, but they cannot be understood as limiting the scope of the invention patent. It should be pointed out that, for ordinary technicians in this field, several variations and improvements can be made without departing from the concept of the present invention, and these all belong to the protection scope of the present invention. Therefore, the protection scope of the patent of the present invention shall be subject to the attached claims.
Claims
1. Use of an outer membrane porin of Aeromonas veronii with broad-spectrum immune protection in the preparation of a vaccine preparation for preventing Aeromonas veronii and Aeromonas hydrophila in freshwater fish, wherein the outer membrane porin is Porin OmpA, the amino acid sequence of Porin OmpA is SEQ ID NO.2, the nucleotide sequence of the gene encoding the outer membrane porin is SEQ ID NO.1, the freshwater Aeromonas veronii strain is AVCA07, and the Aeromonas hydrophila strain is Hn099.
2. The use according to claim 1, It is characterized in that The freshwater fish is grass carp, silver carp, bighead carp, carp, crucian carp, bream, bream, mandarin fish or perch.
Citation Information
Patent Citations
Aeromonas hydrophila outer membrane protein gene prokaryotic expression protein and application thereof
CN104961811A
Subunit nano vaccine of aeromonas hydrophila as well as preparation method and application of subunit nano vaccine
CN115715800A
